Significant improvements in near vision, reading speed, central visual field and related quality of life after ranibizumab treatment of wet age-related macular degeneration

Acta Ophthalmologica

Volumn 88, Issue 4, 2010, Pages 420-425

  Frennesson, Christina ^a   Nilsson, Ulla L ^a   Peebo, Beatrice B ^a   Nilsson, Sven E G ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Best corrected visual acuity; Near vision; Quality of life; Ranibizumab treatment; Reading speed; Visual field; Wet AMD

Indexed keywords

RANIBIZUMAB;

AGED; ARTICLE; BIOMICROSCOPY; CASE STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; EYE FUNDUS; EYE PHOTOGRAPHY; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; READING; RETINA MACULA AGE RELATED DEGENERATION; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL SYSTEM EXAMINATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; INJECTIONS; MALE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; READING; SICKNESS IMPACT PROFILE; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VISUAL FIELDS; VITREOUS BODY; WET MACULAR DEGENERATION;

EID: 77952910606     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2009.01576.x     Document Type: Article

References (16)

1. Antoszyk AN, Tuomi L, Chung CY, Singh A the FOCUS Study Group (2008 Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results. Am J Ophthalmol 145 : 862 874.
2. Bhatnagar P, Spaide RF, Takahashi BS et al. (2007 Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 27 : 846 850.
3. Boyer DS, Antoszyk AN, Awh CC, Bhisitkul RB, Shapiro H, Acharya NR for the MARINA Study Group (2007 Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 114 : 246 252.
4. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S for the ANCHOR Study Group (2006 Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355 : 1432 1444.
5. Chang TS, Bressler NM, Fine JT, Dolan CM, Ward J, Klesert TR the MARINA Study Group (2007 Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol 125 : 1460 1469.
6. Fung AE, Lalwani GA, Rosenfeld PJ et al. (2007 An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 143 : 566 583.
7. Heier JS, Antoszyk AN, Pavan PR et al. (2006a Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 113 : 663 642.
8. Heier JS, Boyer DS, Ciulla TA et al. the FOCUS Study Group (2006b Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year one results of the FOCUS study. Arch Ophthalmol 124 : 1532 1542.
9. ™) in the 2-year ANCHOR study of patients with neovascular age-related macular degeneration (AMD). Invest Ophthalmol Vis Sci 48 : ARVO E-abstract 2872. Available at http://www.iovs.org.
10. Kloos P, Bernasconi P, Estermann S, Bachmann B, Rutishauser Y Thölen A (2008 Visual acuity and magnification requirement after ranibizumab in patients with wet age-related macular degeneration. Klin Monatsbl Augenheilkd 225 : 385 391.
11. Mangione CM (2000 The National Eye Institute 25-item Visual Function Questionnaire (VFQ-25) version 2000. http://www.nei.nih.gov/resources/ visionfunction/manual-cm2000.pdf
12. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY for the MARINA Study Group (2006 Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 : 1419 1431.
13. Schmidt-Erfurth UM, Richard G, Augustin A et al. on behalf of the European Society for Retina Specialists' Guidelines Committee (EURETINA) (2007 Guidance for the treatment of neovascular age-related macular degeneration. Acta Ophthalmol Scand 85 : 486 494. (Pubitemid 47163109)
14. Stefánsson E, Stefánsson G, Sigurdsson S, Briem E (2006 Decimals in data values. Acta Ophthalmol Scand 84 : 449 450.
15. Swamy BN, Chia E-M, Wang JJ, Rochtchina E Mitchell P (2009 Correlation between vision- and health-related quality of life scores. Acta Ophthalmol 87 : 335 339.
16. Trauzettel-Klosinski S, Dieling CH Pietsch B (2003 The influence of visual field defects and other clinical parameters on reading performance: a retrospective study in a low vision population. Vis Impair Res 5 : 83 100.